What is the share price of Healthcare Global Enterprises Ltd (HCG) today?
The share price of HCG as on 4th July 2025 is ₹566.30. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Healthcare Global Enterprises Ltd (HCG) share?
The past returns of Healthcare Global Enterprises Ltd (HCG) share are- Past 1 week: -0.36%
- Past 1 month: 0.28%
- Past 3 months: 6.34%
- Past 6 months: 19.32%
- Past 1 year: 52.48%
- Past 3 years: 108.47%
- Past 5 years: 362.66%
What are the peers or stocks similar to Healthcare Global Enterprises Ltd (HCG)?
The peers or stocks similar to Healthcare Global Enterprises Ltd (HCG) include:What is the market cap of Healthcare Global Enterprises Ltd (HCG) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Healthcare Global Enterprises Ltd (HCG) is ₹7631.60 Cr as of 4th July 2025.What is the 52 week high and low of Healthcare Global Enterprises Ltd (HCG) share?
The 52-week high of Healthcare Global Enterprises Ltd (HCG) is ₹639 and the 52-week low is ₹344.95.What is the PE and PB ratio of Healthcare Global Enterprises Ltd (HCG) stock?
The P/E (price-to-earnings) ratio of Healthcare Global Enterprises Ltd (HCG) is 171.84. The P/B (price-to-book) ratio is 8.82.Which sector does Healthcare Global Enterprises Ltd (HCG) belong to?
Healthcare Global Enterprises Ltd (HCG) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Healthcare Global Enterprises Ltd (HCG) shares?
You can directly buy Healthcare Global Enterprises Ltd (HCG) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Healthcare Global Enterprises Ltd
HCG Share Price
HCG Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
HCG Performance & Key Metrics
HCG Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
171.84 | 8.82 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
36.76 | 6.53 | 0.82% |
from 6 analysts
Price Upside
Earnings Growth
Rev. Growth
HCG Company Profile
Healthcare Global Enterprises Limited is a specialty healthcare provider. The Company is focused on cancer and fertility.
HCG Sentiment Analysis
HCG Sentiment Analysis
HCG Stock Summary · May 2025
The company demonstrated robust financial performance, reporting significant revenue growth of 20% in Q4 and 17% for the full year, driven by strong patient demand and operational efficiency, particularly in emerging centers. While challenges such as increased depreciation and interest costs from recent investments impacted profit after tax, management remains optimistic about future margins as new facilities stabilize. Strategic investments in advanced technologies and digital initiatives have enhanced patient access and outcomes, positioning the company as a leader in oncology care. Additionally, proactive measures to address competitive pressures and optimize working capital reflect a commitment to long-term growth and stakeholder engagement, despite navigating a complex market landscape.
HCG Stock Growth Drivers
HCG Stock Growth Drivers
9Strong Financial Performance
The company reported significant revenue growth, with a 20% increase in Q4 and a 17%
Infrastructure and Technological Advancements
The company has made significant investments in advanced cancer treatment technologies, including the acquisition of
HCG Stock Challenges
HCG Stock Challenges
5Revenue Loss Due to Government Scheme Withdrawal
The withdrawal of a government healthcare scheme in Odisha has resulted in a significant revenue
Integration Challenges of Newly Acquired Facility
The integration of the newly acquired Vizag facility has led to adjustments in operating costs,
HCG Forecast
HCG Forecasts
Price
Revenue
Earnings
HCG Share Price Forecast
HCG Share Price Forecast
All values in ₹
All values in ₹
HCG Company Revenue Forecast
HCG Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
HCG Stock EPS (Earnings Per Share) Forecast
HCG Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
HCG
HCG
Income
Balance Sheet
Cash Flow
HCG Income Statement
HCG Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 709.78 | 861.91 | 986.09 | 1,102.61 | 1,036.17 | 1,560.36 | 1,707.63 | 1,933.35 | 2,258.43 | 2,258.56 | ||||||||||
Raw Materials | 175.92 | 196.64 | 221.49 | 236.35 | 238.17 | 360.98 | 432.38 | 479.37 | 1,835.57 | 1,835.70 | ||||||||||
Power & Fuel Cost | 16.42 | 22.89 | 28.82 | 33.26 | 31.75 | 34.54 | 36.89 | 39.35 | ||||||||||||
Employee Cost | 121.93 | 157.71 | 184.52 | 208.03 | 195.94 | 233.65 | 275.12 | 308.24 | ||||||||||||
Selling & Administrative Expenses | 83.00 | 285.43 | 362.38 | 367.58 | 333.50 | 430.81 | 526.94 | 609.42 | ||||||||||||
Operating & Other expenses | 197.85 | 58.25 | 67.25 | 90.56 | 187.09 | 156.57 | 124.46 | 146.16 | ||||||||||||
EBITDA | 114.66 | 140.99 | 121.63 | 166.83 | 49.72 | 343.81 | 311.84 | 350.81 | 422.86 | 422.86 | ||||||||||
Depreciation/Amortization | 56.83 | 71.46 | 85.09 | 148.45 | 159.22 | 158.28 | 163.47 | 174.36 | 211.34 | 211.34 | ||||||||||
PBIT | 57.83 | 69.53 | 36.54 | 18.38 | -109.50 | 185.53 | 148.37 | 176.45 | 211.52 | 211.52 | ||||||||||
Interest & Other Items | 23.00 | 42.35 | 69.91 | 137.65 | 119.17 | 97.77 | 103.50 | 108.74 | 154.56 | 154.56 | ||||||||||
PBT | 34.83 | 27.18 | -33.37 | -119.27 | -228.67 | 87.76 | 44.87 | 67.71 | 56.96 | 56.96 | ||||||||||
Taxes & Other Items | 12.67 | 6.65 | -8.58 | -12.57 | -35.20 | 34.04 | 15.53 | 19.58 | 12.55 | 12.55 | ||||||||||
Net Income | 22.16 | 20.53 | -24.79 | -106.70 | -193.47 | 53.72 | 29.34 | 48.13 | 44.41 | 44.41 | ||||||||||
EPS | 2.60 | 2.38 | -2.84 | -12.08 | -18.08 | 4.06 | 2.11 | 3.46 | 3.19 | 3.19 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HCG Company Updates
Investor Presentation
HCG Stock Peers
HCG Past Performance & Peer Comparison
HCG Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Healthcare Global Enterprises Ltd | 171.84 | 8.82 | — |
Max Healthcare Institute Ltd | 117.59 | 15.05 | 0.12% |
Apollo Hospitals Enterprise Ltd | 75.23 | 14.86 | 0.37% |
Fortis Healthcare Ltd | 77.43 | 7.01 | 0.13% |
HCG Stock Price Comparison
Compare HCG with any stock or ETFHCG Holdings
HCG Shareholdings
HCG Promoter Holdings Trend
HCG Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
HCG Institutional Holdings Trend
HCG Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
HCG Shareholding Pattern
HCG Shareholding Pattern
HCG Shareholding History
HCG Shareholding History
Mutual Funds Invested in HCG
Mutual Funds Invested in HCG
No mutual funds holding trends are available
Top 5 Mutual Funds holding Healthcare Global Enterprises Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.4876% | Percentage of the fund’s portfolio invested in the stock 1.24% | Change in the portfolio weight of the stock over the last 3 months -0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 30/67 (+12) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.3792% | Percentage of the fund’s portfolio invested in the stock 1.72% | Change in the portfolio weight of the stock over the last 3 months -0.31% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 21/64 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.8834% | Percentage of the fund’s portfolio invested in the stock 3.74% | Change in the portfolio weight of the stock over the last 3 months -1.19% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 11/28 (-2) |
Compare 3-month MF holding change on Screener
smallcases containing HCG stock
smallcases containing HCG stock
Looks like this stock is not in any smallcase yet.
HCG Events
HCG Events
HCG Dividend Trend
HCG has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
HCG Dividend Trend
HCG has not given any dividends in last 5 years
HCG Dividends
HCG Dividends
HCG Stock News & Opinions
HCG Stock News & Opinions
Net profit of Healthcare Global Enterprises declined 65.38% to Rs 7.36 crore in the quarter ended March 2025 as against Rs 21.26 crore during the previous quarter ended March 2024. Sales rose 18.28% to Rs 583.43 crore in the quarter ended March 2025 as against Rs 493.25 crore during the previous quarter ended March 2024. For the full year,net profit declined 7.75% to Rs 44.41 crore in the year ended March 2025 as against Rs 48.14 crore during the previous year ended March 2024. Sales rose 16.26% to Rs 2218.14 crore in the year ended March 2025 as against Rs 1907.87 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales583.43493.25 18 2218.141907.87 16 OPM %18.1118.66 -17.4617.28 - PBDT71.6970.30 2 268.30238.18 13 PBT13.6224.32 -44 56.9663.82 -11 NP7.3621.26 -65 44.4148.14 -8 Powered by Capital Market - Live
Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company on 24 May 2025.Powered by Capital Market - Live
The agreement, which involves a transaction with CVC, a global private markets manager, will see KKR acquire up to 54% of HCG's equity from CVC Asia V at a price of Rs 445 per share. In accordance with the Securities and Exchange Board of India (SEBI) Takeover Regulations, KKR will also conduct an open offer to purchase additional equity shares from public shareholders. Upon completion of the transaction, KKR's total equity stake in HCG is expected to range between 54% and 77%. Dr. BS Ajaikumar, the founder of HCG, will transition to the role of non-executive chairman, where he will focus on driving clinical, academic, and research and development excellence within the organization. The transaction is expected to close by the third quarter of 2025, subject to customary closing conditions and regulatory approvals. Separately, KKR has initiated an open offer to acquire up to 26% of HCG's expanded voting share capital, offering to purchase 3,70,90,327 equity shares at Rs 504.41 per share, for a total consideration of Rs 1870,87,31,842.07. Founded in 1989, HCG is one of India's largest oncology hospital chains. HCG operates 25 medical care centers across 19 cities with best-in-class infrastructure including 2,500 beds, nearly 100 operating theaters and 40 linear accelerator machines (LINACs). Powered by Capital Market - Live
Net profit of Healthcare Global Enterprises rose 22.46% to Rs 6.98 crore in the quarter ended December 2024 as against Rs 5.70 crore during the previous quarter ended December 2023. Sales rose 18.89% to Rs 557.55 crore in the quarter ended December 2024 as against Rs 468.95 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales557.55468.95 19 OPM %15.8516.76 - PBDT53.2255.22 -4 PBT-3.3011.06 PL NP6.985.70 22 Powered by Capital Market - Live
Healthcare Global Enterprises has revised the meeting of the Board of Directors which was scheduled to be held on 13 February 2025. The meeting will now be held on 14 February 2025.Powered by Capital Market - Live
Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live
Net profit of Healthcare Global Enterprises rose 32.57% to Rs 17.99 crore in the quarter ended September 2024 as against Rs 13.57 crore during the previous quarter ended September 2023. Sales rose 13.69% to Rs 552.47 crore in the quarter ended September 2024 as against Rs 485.96 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales552.47485.96 14 OPM %18.5117.41 - PBDT77.3961.13 27 PBT27.6517.92 54 NP17.9913.57 33 Powered by Capital Market - Live
Healthcare Global Enterprises has executed Business Transfer Agreement on 09 November 2024 (BTA), with HCG NCHRI Oncology LLP, a wholly owned subsidiary, for the acquisition of the oncology business of HCG NCHRI Oncology LLP, located at Nagpur, on a slump sale basis. The consideration payable to the Company by the Seller shall not exceed Rs 25 crore, which shall be determined on the effective date of transfer.Powered by Capital Market - Live
Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company on 9 November 2024.Powered by Capital Market - Live
Healthcare Global Enterprises announced that the Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 15.42%, vs industry avg of 12.84%
Over the last 5 years, market share increased from 2.59% to 2.85%